Heva Health review

The costs at a glance

The ninety-nine-dollar figure buys care, not a branded prescription

Heva's weight-loss page labels the Wegovy and Zepbound cards as medical care only. I would put the advertised $99 monthly amount in a care-fee column and leave space beside it for the prescription price. That distinction makes the offer easier to assess: the service may provide access and oversight without subsidizing the medicine. Ask who charges for each component and what happens to the care fee if the prescription cannot be obtained. A small membership is not necessarily a small treatment budget. Compare the completed total with your alternatives only after the exact medication, pharmacy and supply have been identified. For a closer comparison, read our complete GLP-1 cost guide.

Discounted installments still belong to a term

The compounded plan presentation distinguishes month-to-month options from discounted three- and six-month commitments. A displayed semaglutide option is $189 monthly across three payments, which is $567 over that selected term before any unconfirmed extras. I would ask whether each payment triggers a shipment and what remains payable if treatment changes. The site warns that ending a longer commitment early can involve a fee or remaining balance. Paying monthly therefore does not prove that the arrangement is cancellable after one payment. Keep the entire obligation next to the monthly installment when deciding whether a discount is worth accepting.

Formulation details deserve more attention than a product photo

The current page names combinations containing B12 and glycine alongside semaglutide or tirzepatide. That is more specific than a generic GLP-1 label, but it creates an additional question for the consultation: why is this formulation appropriate for the individual patient? I would ask the pharmacy to identify the preparation that will actually arrive and explain the written directions. The product image does not settle the contents or concentration of a filled prescription. Likewise, adding ingredients is not evidence that side effects are reduced or that results improve. Keep an ingredient question separate from the service's advertised convenience and continuity.

Cancellation of care has a different financial effect

Heva's terms permit cancellation through an account, telephone or email and say previously paid membership fees are nonrefundable. Its product page separately discusses early termination of longer plans. I would ask for both answers in the selected order summary: what happens to future care charges, and what financial obligation remains under the chosen treatment term? Those questions become more important if the prescriber recommends stopping or changing a preparation. Do not assume that a medical change automatically cancels a payment agreement. A clear policy should explain the practical path without requiring you to interpret an advertising slogan after another charge appears.

Shipping inclusion does not answer product quality

Heva promotes pharmacy-direct delivery and cold-chain shipping, but delivery convenience and medication approval are separate subjects. FDA states that compounded drugs are not reviewed through its approval process. I would verify the dispensing pharmacy and ask who assesses a shipment that arrives late, warm, damaged or incomplete. The pharmacist's answer should refer to the actual preparation rather than another product's storage rules. Ask whether replacement support continues during a billing dispute, and keep the shipment evidence until the issue is settled. A broad statement about inspected pharmacies does not independently prove the suitability of an individual dispensed preparation. For a closer comparison, read our pharmacy verification guide.

Provider support needs a practical definition

Heva describes an assessment, a treatment recommendation and continuing support as needs change. I would ask what those stages mean for someone using the service: whether the first conversation is live, how often review occurs and how a new symptom reaches a qualified clinician. An administrative specialist can explain plan choices without deciding which medication is medically suitable. That distinction should stay clear when an initial contact discusses both pricing and health goals. Before paying for a longer term, confirm that the follow-up route is workable for your schedule and that records can be shared with your existing care team when needed.

Marketing outcomes should not select the preparation

Heva cites trials of approved medications and displays transformation stories. Those materials do not establish the expected outcome for a compounded combination or for an individual patient. FDA's distinction between approved products and compounded preparations remains relevant even when an ingredient is familiar. I would ask the clinician to explain the proposed treatment in terms of my own history, rather than use the largest percentage on a page as the deciding factor. Be equally cautious about treating a testimonial as a prediction. Care quality, product status, affordability and personal suitability each require a different kind of evidence before enrollment.

My comparison would begin with the care model

Heva is most understandable when its branded care-only route and compounded commitments are treated as separate purchases. I would compare LifeMD for another review of care fees and prescription access, and Found when ongoing support and medication selection are central to the decision. These are commercial alternatives to evaluate, not evidence that any service can prescribe the same product in your state. Ask each one for the next three months of spending and the first point at which you can leave without another obligation. That produces a more useful comparison than placing unlike ninety-nine-dollar and medication-inclusive offers in a single price ranking. For a closer comparison, read our first appointment checklist.

Before you sign up

• What is the complete payment for my exact prescription and supply?
• Which pharmacy and clinical practice will be responsible for my care?
• What changes if my treatment or circumstances change?

Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.